Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As with BPC-157, the bulk of supportive evidence comes from animal models, knee-specific human data is sparse, and it is not approved for therapeutic use in Australia
Long-term AAS use has been linked to glomerular hypertrophy and focal segmental glomerulosclerosis, likely secondary to hyperfiltration, systemic hypertension, and dyslipidaemia
Supplied as lyophilized powder, 10mg per vial
Scientific interest in GHK-Cu also extends to cellular signalling and gene regulation
US$ 25.62
US$ 20.69
US$ 22.18
US$ 21.27
US$ 26.94
US$ 20.08
US$ 27.09
US$ 29.45
US$ 24.54
US$ 20.29
